News
Media Releases

21 June 2018: NZ’s Upside Biotechnologies named as a leading global innovator in 2018 Disrupt 100

12 June 2018: Kiwi regenerative tissue developer raises $2m capital to progress technology commercialisation

30 January 2018: US biomed consortium awards US$300K grant to progress advanced regenerative tissue product

23 August 2017: Upside appoints leading US life sciences executive to Board

23 May 2017: Upside Biotechnologies signs R&D agreement with US Army

22 March 2017: Upside Biotechnologies raises $2.3m in Series A funding round

20 February 2017: David Flacks chairs Upside Biotechnologies

15 November 2016: Skin is the game for regenerative medicine spinoff